J. Freeman, “Clinical decision making in diabetes: Use of glucagon-like peptide-1 (GLP-1) receptor agonists in clinical practice (where, when, and which?)–Introduction”, OFP, vol. 5, no. 1, pp. 31–32, Jan. 2013.